Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer
出版年份 2022 全文链接
标题
Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer
作者
关键词
-
出版物
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 327, Issue 20, Pages 1963
出版商
American Medical Association (AMA)
发表日期
2022-05-24
DOI
10.1001/jama.2022.6147
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial
- (2021) Pamela J. Goodwin et al. npj Breast Cancer
- Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
- (2020) Mayu Hosio et al. ACTA ONCOLOGICA
- The effect of metformin vs placebo on sex hormones in CCTG MA.32
- (2020) Isabel Pimentel et al. JNCI-Journal of the National Cancer Institute
- The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
- (2019) Elisabet Cuyàs et al. Frontiers in Oncology
- The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials
- (2019) J. Rahmani et al. Clinical & Translational Oncology
- A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy
- (2019) Isabel Pimentel et al. BREAST
- Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
- (2018) O. Nanni et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
- (2017) Amir Sonnenblick et al. JOURNAL OF CLINICAL ONCOLOGY
- Unknown
- (2017) Oncotarget
- Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
- (2015) Sirwan M. Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis
- (2015) H. Xu et al. ONCOLOGIST
- Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer
- (2014) Kevin Kalinsky et al. CANCER INVESTIGATION
- Association Between Metformin Therapy and Mortality After Breast Cancer: A population-based study
- (2013) I. C. Lega et al. DIABETES CARE
- Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
- (2012) Saroj Niraula et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin and the Risk of Cancer: Time-related biases in observational studies
- (2012) S. Suissa et al. DIABETES CARE
- A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
- (2012) N. van Leeuwen et al. DIABETOLOGIA
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin in cancer: translational challenges
- (2012) Ryan J O Dowling et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
- (2010) Kimberly S. Peairs et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now